194 related articles for article (PubMed ID: 7756149)
1. Immunohistochemical analysis of chronic discoid and subacute cutaneous lupus erythematosus--relation to immunopathological mechanisms.
Tebbe B; Mazur L; Stadler R; Orfanos CE
Br J Dermatol; 1995 Jan; 132(1):25-31. PubMed ID: 7756149
[TBL] [Abstract][Full Text] [Related]
2. Characterization of the inflammatory infiltrate and expression of endothelial cell adhesion molecules in lupus erythematosus tumidus.
Kuhn A; Sonntag M; Lehmann P; Megahed M; Vestweber D; Ruzicka T
Arch Dermatol Res; 2002 Mar; 294(1-2):6-13. PubMed ID: 12071156
[TBL] [Abstract][Full Text] [Related]
3. T-cell cytokine network in cutaneous lupus erythematosus.
Stein LF; Saed GM; Fivenson DP
J Am Acad Dermatol; 1997 Feb; 36(2 Pt 1):191-6. PubMed ID: 9039167
[TBL] [Abstract][Full Text] [Related]
4. The expression pattern of interferon-inducible proteins reflects the characteristic histological distribution of infiltrating immune cells in different cutaneous lupus erythematosus subsets.
Wenzel J; Zahn S; Mikus S; Wiechert A; Bieber T; Tüting T
Br J Dermatol; 2007 Oct; 157(4):752-7. PubMed ID: 17714558
[TBL] [Abstract][Full Text] [Related]
5. FOXP3+ and CD39+ regulatory T cells in subtypes of cutaneous lupus erythematosus.
Gambichler T; Pätzholz J; Schmitz L; Lahner N; Kreuter A
J Eur Acad Dermatol Venereol; 2015 Oct; 29(10):1972-7. PubMed ID: 25808110
[TBL] [Abstract][Full Text] [Related]
6. Clinical, histologic, and immunofluorescent distinctions between subacute cutaneous lupus erythematosus and discoid lupus erythematosus.
David-Bajar KM; Bennion SD; DeSpain JD; Golitz LE; Lee LA
J Invest Dermatol; 1992 Sep; 99(3):251-7. PubMed ID: 1512459
[TBL] [Abstract][Full Text] [Related]
7. Expression of intercellular adhesion molecule-1 (ICAM-1) and OKM5 in UVA- and UVB-induced lesions in patients with lupus erythematosus and polymorphous light eruption.
Stephansson E; Ros AM
Arch Dermatol Res; 1993; 285(6):328-33. PubMed ID: 7692827
[TBL] [Abstract][Full Text] [Related]
8. Characterization of the dermal infiltrates in Jessner's lymphocytic infiltrate of the skin, polymorphous light eruption and cutaneous lupus erythematosus: differential diagnostic and pathogenetic aspects.
Rijlaarsdam JU; Nieboer C; de Vries E; Willemze R
J Cutan Pathol; 1990 Feb; 17(1):2-8. PubMed ID: 2180999
[TBL] [Abstract][Full Text] [Related]
9. Pathomechanisms of photosensitive lupus erythematosus.
Norris DA
J Invest Dermatol; 1993 Jan; 100(1):58S-68S. PubMed ID: 8093710
[TBL] [Abstract][Full Text] [Related]
10. Selective expansions of T cells expressing V beta 8 and V beta 13 in skin lesions of patients with chronic cutaneous lupus erythematosus.
Furukawa F; Tokura Y; Matsushita K; Iwasaki-Inuzuka K; Onagi-Suzuki K; Yagi H; Wakita H; Takigawa M
J Dermatol; 1996 Oct; 23(10):670-6. PubMed ID: 8973031
[TBL] [Abstract][Full Text] [Related]
11. Papular lesions and cutaneous lupus erythematosus: a comparative clinical and histological study using monoclonal antibodies.
McHugh NJ; Maddison PJ; MacCleod TI; Dean SG; James IE; Goulding NJ; Tan RS
J Rheumatol; 1988 Jul; 15(7):1097-103. PubMed ID: 2459383
[TBL] [Abstract][Full Text] [Related]
12. Matrix metalloproteinases as mediators of tissue injury in different forms of cutaneous lupus erythematosus.
Järvinen TM; Kanninen P; Jeskanen L; Koskenmies S; Panelius J; Hasan T; Ranki A; Saarialho-Kere U
Br J Dermatol; 2007 Nov; 157(5):970-80. PubMed ID: 17854363
[TBL] [Abstract][Full Text] [Related]
13. A comprehensive review of immune-mediated dermatopathology in systemic lupus erythematosus.
Li Q; Wu H; Liao W; Zhao M; Chan V; Li L; Zheng M; Chen G; Zhang J; Lau CS; Lu Q
J Autoimmun; 2018 Sep; 93():1-15. PubMed ID: 30017673
[TBL] [Abstract][Full Text] [Related]
14. Enhanced type I interferon signalling promotes Th1-biased inflammation in cutaneous lupus erythematosus.
Wenzel J; Wörenkämper E; Freutel S; Henze S; Haller O; Bieber T; Tüting T
J Pathol; 2005 Mar; 205(4):435-42. PubMed ID: 15685590
[TBL] [Abstract][Full Text] [Related]
15. In situ expression of B7 and CD28 receptor families in skin lesions of patients with lupus erythematosus.
Denfeld RW; Kind P; Sontheimer RD; Schöpf E; Simon JC
Arthritis Rheum; 1997 May; 40(5):814-21. PubMed ID: 9153541
[TBL] [Abstract][Full Text] [Related]
16. Inflammatory chemokine profiles and their correlations with effector CD4 T cell and regulatory cell subpopulations in cutaneous lupus erythematosus.
Méndez-Flores S; Hernández-Molina G; Azamar-Llamas D; Zúñiga J; Romero-Díaz J; Furuzawa-Carballeda J
Cytokine; 2019 Jul; 119():95-112. PubMed ID: 30903869
[TBL] [Abstract][Full Text] [Related]
17. Apoptosis in different cutaneous manifestations of lupus erythematosus.
Baima B; Sticherling M
Br J Dermatol; 2001 May; 144(5):958-66. PubMed ID: 11359381
[TBL] [Abstract][Full Text] [Related]
18. Scarring skin lesions of discoid lupus erythematosus are characterized by high numbers of skin-homing cytotoxic lymphocytes associated with strong expression of the type I interferon-induced protein MxA.
Wenzel J; Uerlich M; Wörrenkämper E; Freutel S; Bieber T; Tüting T
Br J Dermatol; 2005 Nov; 153(5):1011-5. PubMed ID: 16225615
[TBL] [Abstract][Full Text] [Related]
19. Upregulation of epidermal surface molecule expression in primary and ultraviolet-induced lesions of lupus erythematosus tumidus.
Kuhn A; Sonntag M; Sunderkötter C; Lehmann P; Vestweber D; Ruzicka T
Br J Dermatol; 2002 May; 146(5):801-9. PubMed ID: 12000376
[TBL] [Abstract][Full Text] [Related]
20. IL-17 in cutaneous lupus erythematosus.
Tanasescu C; Balanescu E; Balanescu P; Olteanu R; Badea C; Grancea C; Vagu C; Bleotu C; Ardeleanu C; Georgescu A
Eur J Intern Med; 2010 Jun; 21(3):202-7. PubMed ID: 20493423
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
